Jim is a corporate attorney practicing in the firm’s Mergers & Acquisitions and Emerging Companies practice groups. His practice focuses on a variety of areas, including mergers, acquisitions and divestitures, private equity, venture capital, and general corporate law.
Jim received his J.D. with honors from the University of North Carolina School of Law. During law school, he served as an articles editor and staff member for the North Carolina Law Review. Jim also received his B.A. in History from Duke University, where he competed for four years as a member of the varsity men’s lacrosse team. Prior to joining the firm, Jim was an associate in the Private Equity and Securities & Public Companies practice groups of Ropes & Gray LLP in Boston.
Jim is admitted to practice in Massachusetts and North Carolina.
- Represented a global provider of data, analytics, and insights to the financial services industry in connection with its sale to an international analytics company.
- Represented a regional private equity firm in the acquisition of a local restaurant chain.
- Represented a provider of portfolio management and trading software solutions in its sale to a public fintech services company.
- Served as outside counsel to a public medical device company in the acquisition of a provider of single-use, minimally invasive neurosurgery devices.
- Represented a global investment and advisory firm in co-investments in the wealth management and aerospace and defense industries.
- Served as investor counsel in a $180 million Series A financing of an international small-molecule development company.
- Represented a leading software and IT services company in a majority growth investment transaction with a national private equity firm.
- Served as company counsel to a local microbiome research and products company in its $65 million Series C financing.
- Served as outside counsel to a public semiconductor company in the divestiture of its compute business to a global private equity firm.
- Represented one of the nation’s largest independent, multi-specialty physician groups in a $1.45 billion private equity partnership.